Tofacitinib was first approved by the FDA in 2012 for the treatment of adults with rheumatoid arthritis. In 2017, the FDA approved tofacitinib for the treatment of psoriatic arthritis. In 2018, the FDA approved the medicine to treat ulcerative colitis. Upon FDA approval of tofacitinib, Pfizer was required to conduct a safety clinical trial in patients with rheumatoid arthritis to evaluate the risk of cardiac events, cancer and infections. Based on interim trial results In February 2019 and July 2019, the FDA warned of an increased risk of blood clots and death with dosages of 10 mg twice daily and required a Black Box Warning of such risks on July 30, 2019.
Upon completion of the clinical trial, the FDA released a drug safety communication on February 4, 2021 reported initial safety results showing an increased risk of serious heart–related problems and cancer with use of Xeljanz® and Xeljanz XR® (tofacitinib) in both tested dosages of 5 mg and 10 mg twice daily. While further data may be necessary to determine which cancers Xeljanz® usage is most associated with, if you or a loved one has been diagnosed with any cancer other than skin cancer or smoking–related lung cancer, you may be a candidate to file a Xeljanz® lawsuit
If you would like to pursue a potential claim against Pfizer for a cancer diagnosis, blood clots, pulmonary embolism, deep vein thrombosis, serious cardiac event, or death, please fill out the form above to speak to a Xeljanz® lawyer at the Gori Law Firm about your potential case.
Per the FDA’s communication, patients should not stop taking tofacitinib without first consulting with their health care professionals, as doing so may worsen their condition.
Trust. It is extremely important when it comes to consumer products, medication, and medical procedures. You trust that manufacturers have made products that meet guidelines they claim their products meet. You trust that the medicine or medical device your doctors use when treating you will make you better, not worse. As a Xeljanz® or Xeljanz XR® user, you put your trust in drug maker Pfizer that manufactured a potentially dangerous drug. If you believe your or your loved one’s cancer diagnosis, cardiac event, blood clot, or death was due to the use of Xeljanz® or Xeljanz XR® you need to consult with an experienced Xeljanz® attorney as soon as possible.
Whether you live in Madison County, Illinois, the St. Louis area or anywhere in the U.S., the Xeljanz® lawyers at the Gori Law Firm can help. In fact, we have a national reputation for excellence, experienced attorneys and personal service, all on a contingent fee basis, which means that we only collect fees if we recover damages for you.
At The Gori Law Firm, we have over 35 attorneys across 8 offices who have the complex litigation knowledge that is necessary to pursue your Xeljanz® lawsuit. With a national reputation for excellence, you can rest assured that your case will be handled professionally, efficiently and effectively. With two locations in the St. Louis area, and several others throughout the U.S., our law firm handles cases nationwide.
Our lawyers are particularly compassionate and supportive to our clients throughout the process. As seasoned personal injury attorneys with a nationwide reputation, we have more than 20 years of experience in handling complex lawsuits and will use our knowledge for your case. The Gori Law Firm has obtained more than $3 billion in settlements for previous clients.
To best serve you, it is important to share with us certain information that will help us preliminarily evaluate your potential case by filling out the form at the top of the page. This information that you provide will be personally reviewed by the head of the mass torts group Attorney D. Todd Matthews and Attorney Megan Arvola to determine if our firm may be able to assist you with your case.
Attorney D. Todd Matthews is the leader of the The Gori Law Firm mass torts group. Mr. Matthews is a member of National Trial Lawyers Association, Madison County Bar Association, Missouri Bar Association Solo and Small Firm Committee, Missouri Association of Trial Attorneys, Member, American Association for Justice, American Association for Justice Leaders Forum, National Asbestos Mesothelioma Trial Lawyers, Bar Association of Metropolitan St. Louis. Additionally, he has served on numerous Mass Tort committees in the past and as lead counsel on the Granuflo Litigation in St. Louis City.
Attorney Megan Arvola works under Attorney Matthews on behalf of our injured plaintiffs in mass tort and personal injury litigation. Ms. Arvola comes to The Gori Law Firm, from the chambers of Chief Judge David R. Herndon of the Southern District of Illinois, where she served as a term judicial law clerk for three years. Prior to her federal clerkship, Ms. Arvola graduated from the University of Tulsa College of Law. In 2011, Ms. Arvola received a Burton Award for Legal Achievement, Distinguished Writing Award, in association with the Library of Congress.
Edwardsville, IL
156 North Main Street
Edwardsville, IL 62025
Map & Directions
Washington, DC
1875 Connecticut Ave. NW, 10th Floor
Washington, DC 20009
Map & Directions
New Orleans, LA
909 Poydras Street, Suite 2195
New Orleans, LA 70112
Map & Directions
Los Angeles, CA
3848 Carson Street, Suite 103
Torrance, CA 90503
Map & Directions
St. Louis, MO
1133 Pine Street
St. Louis, MO 63101
Map & Directions
New York, NY
360 Lexington Avenue, 20th Floor
New York, NY 10017
Map & Directions
Orlando, FL
37 N. Orange Ave., Suite 201
Orlando, FL 32801
Map & Directions
Alton, IL
500 E 6th Street
Alton, Illinois 62002
Map & Directions
Disclaimer: Submission of information to The Gori Law Firm does not establish an attorney-client relationship and should not be viewed or understood as doing so. An attorney-client relationship can only be established by the agreement of both the attorney and the client and must be reduced to a written retainer agreement that has been signed by both parties.